GeneOne Life Science, Inc. (KRX:011000)
South Korea
· Delayed Price · Currency is KRW 2,040.00
-5.00 (-0.24%)
At close: Apr 16, 2025, 3:30 PM KST
GeneOne Life Science Revenue
In the year 2024, GeneOne Life Science had annual revenue of 35.72B KRW, down -11.15%. GeneOne Life Science had revenue of 10.51B in the quarter ending December 31, 2024, a decrease of -17.64%.
Revenue
35.72B
Revenue Growth
-11.15%
P/S Ratio
4.56
Revenue / Employee
776.52M
Employees
46
Market Cap
162.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.72B | -4.48B | -11.15% |
| Dec 31, 2023 | 40.20B | -8.52B | -17.48% |
| Dec 31, 2022 | 48.72B | 10.02B | 25.89% |
| Dec 31, 2021 | 38.70B | -2.80B | -6.75% |
| Dec 31, 2020 | 41.50B | 261.48M | 0.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| LigaChem Biosciences | 125.90B |
| PharmaResearch | 350.12B |